Significance and mechanism of androgen receptor overexpression and androgen receptor/mechanistic target of rapamycin cross-talk in hepatocellular carcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Significance and mechanism of androgen receptor overexpression and androgen receptor/mechanistic target of rapamycin cross-talk in hepatocellular carcinoma
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 67, Issue 6, Pages 2271-2286
Publisher
Wiley
Online
2017-12-09
DOI
10.1002/hep.29715
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis
- (2017) Pin Liu et al. HEPATOLOGY
- Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014
- (2017) Ali H. Mokdad et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- MAF1 suppresses AKT-mTOR signaling and liver cancer through activation of PTEN transcription
- (2016) Yue Li et al. HEPATOLOGY
- PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells
- (2016) Jana Samarin et al. HEPATOLOGY
- Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans
- (2016) Lei Li et al. JOURNAL OF HEPATOLOGY
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Feedback Suppression of PI3Kα Signaling in PTEN-Mutated Tumors Is Relieved by Selective Inhibition of PI3Kβ
- (2015) Sarit Schwartz et al. CANCER CELL
- Gender disparity in chronic hepatitis B: Mechanisms of sex hormones
- (2015) Sheng-Han Wang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- SnapShot: Hepatocellular Carcinoma
- (2014) Jens U. Marquardt et al. CANCER CELL
- Rab1A Is an mTORC1 Activator and a Colorectal Oncogene
- (2014) Janice D. Thomas et al. CANCER CELL
- Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis
- (2014) Wen-Lung Ma et al. ENDOCRINE-RELATED CANCER
- Cell cycle-related kinase mediates viral-host signalling to promote hepatitis B virus-associated hepatocarcinogenesis
- (2014) Zhuo Yu et al. GUT
- Effect of Everolimus on Survival in Advanced Hepatocellular Carcinoma After Failure of Sorafenib
- (2014) Andrew X. Zhu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Targeting the mTOR pathway in hepatocellular carcinoma: Current state and future trends
- (2013) Matthias S. Matter et al. JOURNAL OF HEPATOLOGY
- TCPA: a resource for cancer functional proteomics data
- (2013) Jun Li et al. NATURE METHODS
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cell Autonomous Role of PTEN in Regulating Castration-Resistant Prostate Cancer Growth
- (2011) David J. Mulholland et al. CANCER CELL
- Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
- (2011) Brett S. Carver et al. CANCER CELL
- Targeting the mTOR kinase domain: the second generation of mTOR inhibitors
- (2011) Yan-Jie Zhang et al. DRUG DISCOVERY TODAY
- AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2,
- (2011) Coral Ho et al. HEPATOLOGY
- Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection
- (2010) Brad Q. Starley et al. HEPATOLOGY
- Androgen Receptor Promotes Hepatitis B Virus-Induced Hepatocarcinogenesis Through Modulation of Hepatitis B Virus RNA Transcription
- (2010) M. H. Wu et al. Science Translational Medicine
- FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt
- (2009) Huadong Pei et al. CANCER CELL
- Rapamycin delays tumor development in murine livers by inhibiting proliferation of hepatocytes with DNA damage
- (2009) Laura Elisa Buitrago-Molina et al. HEPATOLOGY
- Identification of androgen response elements in the enhancer I of hepatitis B virus: A mechanism for sex disparity in chronic hepatitis B
- (2009) Sheng-Han Wang et al. HEPATOLOGY
- Androgen Receptor Is a New Potential Therapeutic Target for the Treatment of Hepatocellular Carcinoma
- (2008) Weng–Lung Ma et al. GASTROENTEROLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival
- (2008) Y Wang et al. ONCOGENE
- Role of sex steroid receptors in pathobiology of hepatocellular carcinoma
- (2008) Mamta Kalra et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Is human hepatocellular carcinoma a hormone-responsive tumor?
- (2008) Massimo Di Maio WORLD JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started